Resources

Past Presentation

Medications for OUD: Who Should Get What When? | February 7, 2019

Date of Presentation: February 7, 2019

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #buprenorphine  #mat  #methadone  #naltrexone  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other clinical variables when used for treating opioid use disorder.

 

Presenter Bio:

Dr. Jessica Gregg

Jessica Gregg, MD, PhD, is an Associate Professor of Medicine at Oregon Health and Science University. She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the Director of the university’s addiction medicine ECHO clinics, as Associate Program Director for OHSU’s addiction medicine fellowship, and as Medical Director of the OHSU HRBR clinic, which provides low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.

Resource Provided:

Date added: February 7, 2019